Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00181597 | Trilostane for Androgen-Independent Prostate Cancer | completed | Phase 2 | 24 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01487720 | GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer | completed | Phase 2 | 33 | Asan Medical CenterOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT00681148 | Botulinum Toxin Injection With Prostate Brachytherapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT00086736 | Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | completed | Phase 2 | 34 | University of Alabama at BirminghamOTHER | 1 | Nov 19, 2013 | clinicaltrials |
| NCT00945477 | Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade | terminated | Phase 2 | 11 | Illinois CancerCare, P.C.OTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00028353 | A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN) | completed | Phase 2 | 500 | GTxINDUSTRY | 1 | Nov 15, 2013 | clinicaltrials |
| NCT00005939 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | unknown | Phase 1 / Phase 2 | — | Center for Molecular MedicineOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00054015 | 3-AP in Treating Patients With Advanced Prostate Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00348998 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | unknown | Phase 2 | 18 | Virginia Mason Hospital/Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00814892 | Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer | terminated | Phase 2 | 2 | Mayo ClinicOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Milton S. Hershey Medical CenterOTHER | 0 | Sep 27, 2013 | clinicaltrials |
| NCT00020995 | Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00354497 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | unknown | Phase 2 | 800 | Lawrence Livermore National Laboratory at University of CaliforniaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00765479 | Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | completed | Phase 2 / Phase 3 | 284 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00748358 | An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer(PROSUT) | completed | Phase 2 | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 18, 2013 | clinicaltrials |
| NCT00006002 | SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 36 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00561262 | High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 60 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00561314 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 33 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00987675 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00988130 | High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01193855 | Dutasteride in Treating Patients With Prostate Cancer | unknown | Phase 2 | 42 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00908141 | GM-CSF in Treating Patients With Relapsed Prostate Cancer | completed | Phase 2 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00685633 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Aug 20, 2013 | clinicaltrials |
| NCT00425334 | Safety Study of Hemospan® in Prostatectomy Patients | completed | Phase 2 | 20 | SangartINDUSTRY | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00554918 | Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy | completed | Phase 2 | 300 | University Hospital BirminghamOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01901042 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | completed | Phase 2 / Phase 3 | 20 | Federal University of Mato GrossoOTHER | 0 | Jul 17, 2013 | clinicaltrials |
| NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 41 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 7 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00181584 | Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | completed | Phase 2 | 60 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00738140 | Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors | completed | Phase 2 | 15 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00003517 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00081172 | Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00485303 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | completed | Phase 2 | 58 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT00003104 | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00002637 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003394 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 1 / Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00006019 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00012142 | CCI-779 in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00016393 | BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00025194 | Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00078910 | Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00992186 | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer | completed | Phase 2 | 46 | Centocor Research & Development, Inc.INDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00003740 | Trastuzumab in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00537381 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | completed | Phase 2 | 131 | Centocor, Inc.INDUSTRY | 10 | Jun 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 5, 2013source: clinicaltrials